markdown

Penumbra, Inc. - Company Market Research Report

Company Overview

Name: Penumbra, Inc.
Mission: Innovating novel technologies to help as many people as possible.
Founded: No information is available.
Founders: No information is available.
Key People:

Adam Elsesser: President, Chairman, and Chief Executive Officer

Ben Sorci: Executive Vice President, Operations

Ben Tompkins: Executive Vice President, Development and Compliance

Gita Barry: President, Immersive Healthcare

James F. Benenati, M.D., FSIR: Chief Medical Officer

Jason Mills: Executive Vice President, Strategy

Johanna Roberts: Executive Vice President, General Counsel and Secretary

Lambert Shiu: Chief Accounting Officer

Maggie Yuen: Chief Financial Officer

Pankaj Tiwari: Executive Vice President and Chief Information Officer

Shruthi Narayan: EVP and General Manager, Interventional

Headquarters: Alameda, California, USA
Number of Employees: No information is available.
Revenue:

First Quarter 2024: $278.7 million

Fourth Quarter 2023: $284.7 million

Full Year 2023: $1,058.5 million

Notable For: A leader in healthcare innovation, focusing on developing novel therapies and devices for challenging medical conditions.

Products

Neuro

1. RED Reperfusion Catheters & Penumbra System

Description: Neuro Thrombectomy devices designed for clot removal in neurovascular treatments.

Key Features: Intelligent Aspiration technology, precision in clot detection.

2. Penumbra JET Reperfusion Catheters

Description: Designed for rapid and effective clot removal.

Key Features: High degrees of flexibility and durability.

3. 3D Revascularization Device

Description: A device focused on revascularization post-clot removal.

Key Features: Enhanced structural integrity for effective revascularization.

Vascular

1. Peripheral Embolization System (POD, Ruby Coil)

Description: Systems designed for arterial and venous embolization.

Key Features: Large volume platinum-based coils, compatibility with high-flow microcatheters.

Immersive Healthcare

1. REAL y-Series

Description: A multi-disciplinary VR rehabilitation tool designed for patient monitoring and goal advancement.

Key Features:

REAL Pinball: Functional movement pattern improvement.

Mindful Market: Advanced cognitive abilities.

Happy Valley: Physical and cognitive rehabilitation.

Music in Motion: Rhythmic body movements.

Island Antics: Multi-directional movements aiding in task completion.

Pleasant Cove: Cognitive and motor skills improvement.

Recent Developments

1. First Quarter 2024 Financial Results:

Revenue: $278.7 million, a 15.4% increase from the first quarter of 2023.

Key Growth: U.S. thrombectomy revenue increased by 35.2%.

2. Fourth Quarter and Full Year 2023 Financial Results:

Revenue: $284.7 million for Q4 2023; $1,058.5 million for the full year 2023.

Key Growth: Global thrombectomy products revenue grew by 42.4% in Q4 2023.

3. Partnership and Research:

STORM-PE Trial: A multi-center randomized controlled trial for the Lightning Flash™ technology evaluating anticoagulation plus CAVT for PE treatment in partnership with PERT Consortium.

Partnerships

PERT Consortium: Collaboration for the STORM-PE trial focused on advanced PE treatment.

Financial Outlook

2024 Revenue Projection:

Total Revenue: $1,230.0 million to $1,270.0 million

U.S. Thrombectomy Growth: 27% to 30%

Gross Margin Expansion: 100 to 150 bps

Contact Information

Headquarters:
Penumbra, Inc.
One Penumbra Place
Alameda, CA 94502, USA

Phone:
+1.510.748.3200
Email:
info@penumbrainc.com

Website:
[www.penumbrainc.com](https://www.penumbrainc.com)

Global Offices Contacts:

Europe: Mariendorfer Damm 1, 12099 Berlin, Germany.

Latin America: Av. Brigadeiro Faria Lima 1336, cj 82, CEP 01451-00, São Paulo/SP, Brazil.

Other Locations: Livermore, Salt Lake City, Roseville.

Stock Information

Change: ▼ $-0.08 (-0.04%)

Volume: 266,204

Market Cap: $7.859 billion

Shares Outstanding: 38,843,936

52 Week High/Low: $302.00 / $148.00

For more detailed information, including financial statements and investor relations, visit the [Investors Section](https://www.penumbrainc.com/investors) on Penumbra’s website.

Penumbra, Inc.